Hormone replacement therapy (HRT) induces acquired resistance to activated protein C (APC): results from a randomized, double-blind, clinical trial - Hoibraaten, E; Mowinckel, M-C; de Ronde, H; Bertina, RM; Strandberg, PM (Blood, 2000)
(abstract 3528).